New product intros (acetylsalicylic acid/omeprazole [new formulation], autologous skeletal myoblast sheets, brodalumab [new formulation], buprenorphine [new formulation], eteplirsen, ezetimibe [new indication], lesinurad sodium, opicapone, sofosbuvir/velpatasvir [new combination], sufentanil [new formulation])
Keyword(s):
Keyword(s):
Keyword(s):